(146) used a 3D-dense UNet on only T2 images to simultaneously segment the tumor and predict the presence of MGMT promoter methylation with a mean three-fold cross-validation accuracy of 0.95 (sensitivity 0.96, specificity 0.92, AUC 0.93, Dice score 0.82). The gene discussed is MGMT; the disease is neoplasm.